Supernus Pharmaceuticals, Inc. (SUPN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Supernus Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -72.78x | 26.97x | 1199.30x | 31.53x | 28.98x | 10.43x |
| P/B Ratio | 2.64x | 1.92x | 1.71x | 2.16x | 1.90x | 1.78x |
| P/S Ratio | 3.90x | 3.01x | 2.60x | 2.87x | 2.67x | 2.54x |
| Profitability | ||||||
| Gross Margin | 89.6% | 88.2% | 86.2% | 86.9% | 87.1% | 89.9% |
| Operating Margin | -5.1% | 12.3% | -0.9% | 6.9% | 14.8% | 33.4% |
| Net Margin | -5.4% | 11.2% | 0.2% | 9.1% | 9.2% | 24.4% |
| EBITDA Margin | 5.9% | 26.9% | 14.8% | 23.0% | 22.3% | 40.5% |
| Liquidity | ||||||
| Current Ratio | 1.90x | 2.35x | 1.70x | 1.07x | 1.91x | 2.57x |
| Quick Ratio | 1.66x | 2.16x | 1.43x | 0.93x | 1.63x | 2.37x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.03x | 0.05x | 0.50x | 0.52x | 0.56x |
YoY = year-over-year change. Source: FMP..